Paper3333882
The metabolism and biopharmaceutics of spironolactone in man.
Overdiek HW and 1 other. Rev Drug Metab Drug Interact, 1987. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. The metabolism and biopharmaceutics of spironolactone in man. Papers, record 3333882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3333882
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Spironolactone | Major topic |
| Aged | |
| Biological Availability | |
| Biotransformation | |
| Humans |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41282597 | Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41282597 | PubMed |
| 40143132 | Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143132 | PubMed |
| 37647894 | Approach to the Patient: Reninoma. | J Clin Endocrinol Metab | 2024 | https://conductscience.org/library/papers/37647894 | PubMed |
| 37439256 | Biomarkers to Guide Medical Therapy in Primary Aldosteronism. | Endocr Rev | 2024 | https://conductscience.org/library/papers/37439256 | PubMed |
| 37261664 | Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions. | Clin Pharmacokinet | 2023 | https://conductscience.org/library/papers/37261664 | PubMed |
| 37137720 | METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl S-Thiol Methyl Transferase Activity in Liver. | Drug Metab Dispos | 2023 | https://conductscience.org/library/papers/37137720 | PubMed |
| 36744253 | Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36744253 | PubMed |
| 34668529 | Pannexin 1: a novel regulator of acute hypoxic pulmonary vasoconstriction. | Cardiovasc Res | 2022 | https://conductscience.org/library/papers/34668529 | PubMed |
| 29798905 | Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone". | Circ Res | 2018 | https://conductscience.org/library/papers/29798905 | PubMed |
| 28634268 | 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. | J Endocrinol | 2017 | https://conductscience.org/library/papers/28634268 | PubMed |
| 25473283 | Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. | Int J Nanomedicine | 2014 | https://conductscience.org/library/papers/25473283 | PubMed |
| 18078011 | Aldosterone antagonism in heart failure. | Vasc Health Risk Manag | 2007 | https://conductscience.org/library/papers/18078011 | PubMed |
| 15257869 | Aldosterone-receptor antagonism and end-stage renal disease. | Curr Hypertens Rep | 2004 | https://conductscience.org/library/papers/15257869 | PubMed |
| 14669838 | Aldosterone receptor antagonists: biology and novel therapeutical applications. | J Endocrinol Invest | 2003 | https://conductscience.org/library/papers/14669838 | PubMed |
| 12974768 | Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/12974768 | PubMed |
| 8144871 | Hirsutism and the effectiveness of spironolactone in its management. | J Endocrinol Invest | 1993 | https://conductscience.org/library/papers/8144871 | PubMed |
| 1884726 | Improved bioavailability from a spironolactone beta-cyclodextrin complex. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1884726 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3333882
GET https://conductscience.org/api/papers/v1/3333882/authors